OncoSil Medical Limited (OSL.AX)
AUD 0.01
(-14.29%)
AUD 0.01
(-14.29%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 70.67 Thousand AUD | -58.62% |
| 2023 | 170.8 Thousand AUD | -43.85% |
| 2022 | 304.21 Thousand AUD | -37.19% |
| 2021 | 484.36 Thousand AUD | 340.57% |
| 2020 | 109.94 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 148.86 Thousand AUD | -59.5% |
| 2007 | 367.55 Thousand AUD | -40.47% |
| 2006 | 617.43 Thousand AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 107.12 Thousand AUD | 0.0% |
| 2024 Q4 | 70.67 Thousand AUD | 0.0% |
| 2024 FY | 70.67 Thousand AUD | -58.62% |
| 2023 FY | 170.8 Thousand AUD | -43.85% |
| 2023 Q4 | 170.8 Thousand AUD | 0.0% |
| 2023 Q2 | 222.76 Thousand AUD | 0.0% |
| 2022 FY | 304.21 Thousand AUD | -37.19% |
| 2022 Q2 | 403.96 Thousand AUD | 0.0% |
| 2022 Q4 | 304.21 Thousand AUD | 0.0% |
| 2021 Q2 | 97.23 Thousand AUD | 0.0% |
| 2021 Q4 | 484.36 Thousand AUD | 0.0% |
| 2021 FY | 484.36 Thousand AUD | 340.57% |
| 2020 FY | 109.94 Thousand AUD | 0.0% |
| 2020 Q4 | 109.94 Thousand AUD | 0.0% |
| 2020 Q2 | 229.56 Thousand AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q2 | 60.45 Thousand AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2008 FY | 148.86 Thousand AUD | -59.5% |
| 2008 Q4 | 148.86 Thousand AUD | 0.0% |
| 2007 Q4 | 367.55 Thousand AUD | 0.0% |
| 2007 FY | 367.55 Thousand AUD | -40.47% |
| 2006 FY | 617.43 Thousand AUD | 0.0% |
| 2006 Q4 | 617.43 Thousand AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 98.62% |
| Adherium Limited | 93.2 Thousand AUD | 24.176% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 98.963% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | 16.532% |
| Anteris Technologies Ltd | 2.33 Million AUD | 96.971% |
| Control Bionics Limited | 961.73 Thousand AUD | 92.652% |
| CardieX Limited | 3.22 Million AUD | 97.81% |
| Compumedics Limited | 6.97 Million AUD | 98.987% |
| Cochlear Limited | 243.7 Million AUD | 99.971% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 97.949% |
| Cyclopharm Limited | 4.22 Million AUD | 98.328% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 97.563% |
| Nova Eye Medical Limited | 3.34 Million AUD | 97.89% |
| HeraMED Limited | 260.65 Thousand AUD | 72.887% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 99.55% |
| ImpediMed Limited | 1.14 Million AUD | 93.817% |
| InhaleRx Limited | 560.27 Thousand AUD | 87.386% |
| LBT Innovations Limited | 1.74 Million AUD | 95.945% |
| Micro-X Limited | 4.05 Million AUD | 98.257% |
| Neurotech International Limited | - AUD | -Infinity% |
| PolyNovo Limited | 15.38 Million AUD | 99.54% |
| Respiri Limited | 1.17 Million AUD | 93.993% |
| SomnoMed Limited | 1.01 Million AUD | 93.044% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 98.578% |
| Uscom Limited | 989.27 Thousand AUD | 92.856% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | 77.36% |